Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease

被引：0

作者：

Aliberti, Stefano ^{[1
,2
]}

Sotgiu, Giovanni ^{[3
]}

Castellotti, Paola ^{[4
]}

Ferrarese, Maurizio ^{[4
]}

Pancini, Lisa ^{[4
]}

Pasat, Ana ^{[4
]}

Vanoni, Nicolo ^{[1
,2
]}

Spotti, Maura ^{[2
,5
]}

Mazzola, Ester ^{[4
]}

Gramegna, Andrea ^{[1
,2
]}

Saderi, Laura ^{[3
]}

Perno, Carlo Federico ^{[4
]}

Van Ingen, Jakko ^{[6
]}

Codecasa, Luigi Ruffo ^{[4
]}

Blasi, Francesco ^{[1
,2
]}

机构：

[1] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Internal Med Dept,Resp Unit, Milan, Italy

[2] Cyst Fibrosis Adult Ctr, Milan, Italy

[3] Univ Sassari, Clin Epidemiol & Med Stat Unit, Dept Med, Surg,Expt Sci, Sassari, Italy

[4] Osped Niguarda Ca Granda, Villa Marelli Inst, TB Reference Ctr & Lab, Milan, Italy

[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Internal Med, Resp Unit, Milan, Italy

[6] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands

来源：

EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷

关键词：

Chronic diseases;

D O I：

10.1183/13993003.congress-2019.PA2936

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

PA2936

引用

页数：2

共 50 条

[1] Factors predisposing to non-tuberculous mycobacterial lung disease in the patients with respiratory isolates of non-tuberculous mycobacteria
Szturmowicz, Monika
Siemion-Szczesniak, Izabela
Wyrostkiewicz, Dorota
Klatt, Magdalena
Brzezinska, Sylwia
Zaboset, Anna
Lewandowska, Anna
Filipczak, Dorota
Oniszh, Karina
Skoczylas, Agnieszka
Augustynowicz-Kopec, Ewa
Kus, Jan
ADVANCES IN RESPIRATORY MEDICINE, 2018, 86 (06) : 261 - 267
[2] Ancillary treatment of patients with lung disease due to non-tuberculous mycobacteria: a narrative review
Youssefnia, Artmis
Pierre, Alicia
Hoder, Jeffrey M.
MacDonald, Michelle
Shaffer, Monica J. B.
Friedman, Jessica
Mehler, Philip S.
Bontempo, Amanda
Silva, Francisco C. N. da
Chan, Edward D.
JOURNAL OF THORACIC DISEASE, 2022, 14 (09) : 3575 - 3597
[3] Survival of Lung Transplant Patients Receiving Treatment for Non-Tuberculous Mycobacteria
Lashari, B. H.
Van Der Rijst, N.
Sullivan, N.
Shenoy, K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[4] Real-life evaluation of clinical outcomes in patients undergoing treatment for non-tuberculous mycobacteria lung disease: A ten-year cohort study
Aliberti, Stefano
Sotgiu, Giovanni
Castellotti, Paola
Ferrarese, Maurizio
Pancini, Lisa
Pasat, Ana
Vanoni, Nicolo
Spotti, Maura
Mazzola, Ester
Gramegna, Andrea
Saderi, Laura
Perno, Carlo Federico
van Ingen, Jakko
Codecasa, Luigi Ruffo
Blasi, Francesco
RESPIRATORY MEDICINE, 2020, 164
[5] Treatment of pulmonary disease caused by non-tuberculous mycobacteria
van Ingen, Jakko
LANCET RESPIRATORY MEDICINE, 2015, 3 (03): : 179 - 180
[6] NON-TUBERCULOUS MYCOBACTERIA IN PATIENTS WITH COPD - FREQUENTLY POOR OUTCOMES DESPITE TREATMENT
Malhotra, A. M.
Milbum, H.
Breen, R.
THORAX, 2014, 69 : A112 - A112
[7] PrednisoneProgression of non-tuberculous mycobacteria lung disease: case report
Reactions Weekly, 2023, 1978 (1) : 322 - 322
[8] Immunological markers of lung disease due to non-tuberculous mycobacteria
Lim, Andrew
Allison, Caris
Tan, Dino Bee Aik
Oliver, Ben
Price, Patricia
Waterer, Grant
DISEASE MARKERS, 2010, 29 (02) : 103 - 109
[9] Non-Tuberculous Mycobacteria in Interstitial Lung Disease: To Treat or Not to Treat?
Oakland, H. T.
Taskar, V. S.
Lasky, J. A.
Klingsberg, R. C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[10] Non-tuberculous mycobacteria: an emerging disease?
Altet Gomez, N.
ANALES DE PEDIATRIA, 2009, 71 (03): : 185 - 188

← 1 2 3 4 5 →